+13.1%
GSK vs BIDU
-34.6%
+47.7%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BIDU | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +4.5% | +0.5% | +4.9% |
| 7D | +4.9% | +1.2% | +3.8% | +4.9% |
| 30D | +9.9% | -7.5% | +17.4% | +10.0% |
| 3M | +0.2% | -28.6% | +28.7% | +0.8% |
| 6M | +2.3% | -36.9% | +39.2% | +3.3% |
| YTD | +7.1% | -38.4% | +45.5% | +6.6% |
| 1Y | +13.1% | -35.7% | +48.8% | +12.7% |
| All | +13.1% | -34.6% | +47.7% | +12.7% |
Cumulative growth
Daily Returns
Daily percentage return beside BIDU.
Daily Out/Under-Performance
Portfolio return minus BIDU return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BIDU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BIDU wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling